Vol 51 No 03

Urologists should watch early adopters of MVPs to know what to expect.

Patient communication is key when implementing new policy.

"Until a better option comes along, its low cost (mesh alone) and ease of use allows a standardized approach in an appropriately selected patient," writes Gopal H. Badlani, MD.

"It will only be when the indications for focal therapy are expanded to higher-grade and larger tumors that we will begin to learn about the true efficacy of this approach," writes Badar M. Mian, MD.

"It’s hard for me to believe urology’s the most stressful job, although it’s very stressful," says Aaron Bayne, MD.

"When you plan to retire determines how long you must save for and how long investment returns can compound," writes Jeff Witz, CFP.

"Over the past 10 to 15 years, tremendous efforts have gone into robotic surgical innovation to improve perioperative morbidity for patients with bladder cancer undergoing RC," write Andrew M. Wood, MD, and Nima Almassi, MD.

"The different outcomes in [these] cases highlight the contextual nature of medical care," writes Kenton H. Steele, Esq.

The study considered 4 dimensions of the workplace: equal access, work-life balance, freedom from gender bias, and supportive leadership.

In this interview, Ira Sharlip, MD, explains the potential dangers these products pose and what urologists can do to help protect their patients.

"Patients with intermediate-risk NMIBC remain an incredibly heterogeneous group," says Wei Shen Tan, MD, PhD.

In response to the findings, The American Cancer Society is launching IMPACT, an initiative aimed at reducing prostate cancer mortality.